Histamine 2 receptor antagonists do not improve the outcomes of hospitalized COVID-19 patients

INTRODUCTION: Some observational studies have demonstrated the benefit of famotidine in COVID-19-infected individuals. The preference of using an H(2) receptor antagonist (H(2)RA) over proton pump inhibitors (PPI) during the COVID-19 pandemic has been questioned by clinicians. AIM: To compare the ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Amjad, Waseem, Kamal, Faisal, Malik, Adnan, Singh, Ritu, Mahmood, Sultan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165339/
https://www.ncbi.nlm.nih.gov/pubmed/35664030
http://dx.doi.org/10.5114/pg.2021.107799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165339/
https://www.ncbi.nlm.nih.gov/pubmed/35664030
http://dx.doi.org/10.5114/pg.2021.107799

Ejemplares similares